A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Haukeland University Hospital /ID# 210162, Bergen

Paddington Testing Co., Inc. /ID# 207079, Philadelphia

West Virginia University Hospitals /ID# 206792, Morgantown

Cincinnati Children's Hospital /ID# 207071, Cincinnati

Dawes Fretzin, LLC /ID# 214958, Indianapolis

Arlington Research Center, Inc /ID# 222901, Arlington

Children's Hospital Los Angeles /ID# 206042, Los Angeles

Oregon Medical Research Center /ID# 206226, Portland

Beach Pediatrics /ID# 207834, Huntington Beach

Pediatric Skin Research, LLC /ID# 213468, Coral Gables

Rybear, Inc /ID# 231801, Fort Lauderdale

IACT Health-Columbus /ID# 216370, Columbus

Northwestern University Feinberg School of Medicine /ID# 206224, Chicago

Duplicate_Washington University of St. Louis /ID# 206972, St Louis

University of New Mexico School of Medicine /ID# 206757, Albuquerque

Penn State University and Milton S. Hershey Medical Center /ID# 207096, Hershey

Rikshospitalet OUS HF /ID# 210163, Oslo

Alma M. Cruz Santana, MD-Private practice /ID# 214890, Carolina